The purpose of this legislation, known as the "Innovate to Save Lives Act," is to encourage small businesses to engage in research aimed at addressing serious drug threats, particularly those related to emerging drugs, fentanyl, and methamphetamine. By providing financial incentives, the law aims to stimulate innovation in developing solutions to mitigate the impacts of these drugs on public health. Key provisions of the law include a new tax credit for small businesses.